Literature DB >> 3030730

Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.

J H Verheijen, M P Caspers, G T Chang, G A de Munk, P H Pouwels, B E Enger-Valk.   

Abstract

Human tissue-type plasminogen activator (t-PA) catalyses the conversion of inactive plasminogen into active plasmin, the main fibrinolytic enzyme. This process is confined to the fibrin surface by specific binding of t-PA to fibrin and stimulation of its activity by fibrin. Tissue-type plasminogen activator contains five domains designated finger, growth factor, kringle 1, kringle 2 and protease. The involvement of the domains in fibrin specificity was investigated with a set of variant proteins lacking one or more domains. Variant proteins were produced by expression in Chinese hamster ovary cells of plasmids containing part of the coding sequence for the activator. It was found that kringle 2 domain only is involved in stimulation of activity by fibrin. In the absence of plasminogen and at low concentration of fibrin, binding of t-PA is mainly due to the finger domain, while at high fibrin concentrations also kringle 2 is involved in fibrin binding. In the presence of plasminogen, fibrin binding of the kringle 2 region of t-PA also becomes important at low fibrin concentrations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3030730      PMCID: PMC1167389          DOI: 10.1002/j.1460-2075.1986.tb04678.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  25 in total

1.  Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe.

Authors:  A J van Zonneveld; G T Chang; J van den Berg; T Kooistra; J H Verheijen; H Pannekoek; C Kluft
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

Authors:  W Weimar; J Stibbe; A J van Seyen; A Billiau; P De Somer; D Collen
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

4.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

5.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.

Authors:  D Pennica; W E Holmes; W J Kohr; R N Harkins; G A Vehar; C A Ward; W F Bennett; E Yelverton; P H Seeburg; H L Heyneker; D V Goeddel; D Collen
Journal:  Nature       Date:  1983-01-20       Impact factor: 49.962

6.  A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.

Authors:  J H Verheijen; E Mullaart; G T Chang; C Kluft; G Wijngaards
Journal:  Thromb Haemost       Date:  1982-12-27       Impact factor: 5.249

7.  Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.

Authors:  L Bányai; A Váradi; L Patthy
Journal:  FEBS Lett       Date:  1983-10-31       Impact factor: 4.124

8.  Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue.

Authors:  E Frost; J Williams
Journal:  Virology       Date:  1978-11       Impact factor: 3.616

9.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.

Authors:  F Van de Werf; P A Ludbrook; S R Bergmann; A J Tiefenbrunn; K A Fox; H de Geest; M Verstraete; D Collen; B E Sobel
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

View more
  17 in total

Review 1.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 2.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro.

Authors:  T D Brooks; J Slomp; P H Quax; A C De Bart; M T Spencer; J H Verheijen; P A Charlton
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  High-level expression of a novel recombinant human plasminogen activator (rhPA) in the milk of transgenic rabbits and its thrombolytic bioactivity in vitro.

Authors:  Shaozheng Song; Xin Ge; Yaobin Cheng; Rui Lu; Ting Zhang; Baoli Yu; Xueqiao Ji; Zhengqiang Qi; Yao Rong; Yuguo Yuan; Yong Cheng
Journal:  Mol Biol Rep       Date:  2016-05-26       Impact factor: 2.316

Review 5.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

6.  The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.

Authors:  Colin Longstaff; Craig Thelwell; Stella C Williams; Marta M C G Silva; László Szabó; Krasimir Kolev
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

7.  Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.

Authors:  J M Edelberg; S V Pizzo
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

Review 8.  tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.

Authors:  Linda Fredriksson; Daniel A Lawrence; Robert L Medcalf
Journal:  Semin Thromb Hemost       Date:  2016-09-27       Impact factor: 4.180

Review 9.  New strategies in the development of thrombolytic agents.

Authors:  H R Lijnen; D Collen
Journal:  Blut       Date:  1988-10

10.  Interactions of a fluorescently labeled peptide with kringle domains in proteins.

Authors:  A Balciunas; G M Fless; A M Scanu; R A Copeland
Journal:  J Protein Chem       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.